Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) gapped up prior to trading on Thursday following a better than expected earnings announcement. The stock had previously closed at $24.39, but opened at $27.59. Trupanion shares last traded at $27.6920, with a volume of 171,742 shares trading hands.
The financial services provider reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The company had revenue of $392.93 million during the quarter, compared to analysts’ expectations of $389.72 million. During the same quarter in the previous year, the business posted $0.22 earnings per share. The firm’s quarterly revenue was up 11.1% compared to the same quarter last year.
More Trupanion News
Here are the key news stories impacting Trupanion this week:
- Positive Sentiment: Quarterly earnings and revenue beat estimates. Trupanion reported adjusted earnings of $0.16 per share, above the $0.11 consensus estimate, while revenue reached $392.9 million versus expectations of $389.7 million. Revenue increased 11.1% year over year. Trupanion Q2 Earnings and Revenues Beat Estimates
- Positive Sentiment: Third-quarter revenue guidance was above consensus. Management forecast Q3 revenue of $399 million to $405 million, compared with analysts’ estimate of approximately $397.8 million, suggesting continued revenue momentum. Trupanion Reports Second Quarter 2026 Results
- Positive Sentiment: Management emphasized improving business economics. Trupanion said it is focused on expanding margins, improving the economics of new member enrollments and deploying capital with discipline—initiatives that could support profitability and cash generation over time. Trupanion Q2 2026 Earnings Call Transcript
- Neutral Sentiment: Full-year revenue guidance was broadly in line. The company maintained a 2026 revenue outlook of approximately $1.6 billion, matching the consensus estimate. Trupanion Earnings Report
- Negative Sentiment: Year-over-year EPS declined. The $0.16 quarterly EPS result compared with $0.22 in the same period last year, indicating that profitability remains an area investors will monitor despite the earnings beat. Trupanion Q2 Earnings Snapshot
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on TRUP
Insider Buying and Selling
In related news, CFO Fawwad Qureshi sold 6,177 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $22.18, for a total value of $137,005.86. Following the completion of the sale, the chief financial officer directly owned 2,081 shares in the company, valued at approximately $46,156.58. The trade was a 74.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO John R. Gallagher sold 3,603 shares of the stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $21.69, for a total transaction of $78,149.07. Following the transaction, the chief operating officer directly owned 33,065 shares in the company, valued at approximately $717,179.85. This represents a 9.83% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 17,807 shares of company stock valued at $394,452. Insiders own 5.58% of the company’s stock.
Institutional Investors Weigh In On Trupanion
A number of institutional investors have recently added to or reduced their stakes in TRUP. Kopion Asset Management LLC increased its stake in Trupanion by 30.9% during the second quarter. Kopion Asset Management LLC now owns 522,999 shares of the financial services provider’s stock worth $12,955,000 after acquiring an additional 123,308 shares during the last quarter. Parallel Advisors LLC lifted its stake in shares of Trupanion by 1,831.9% in the 1st quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock valued at $47,000 after purchasing an additional 1,722 shares in the last quarter. Liontrust Investment Partners LLP lifted its stake in shares of Trupanion by 23.8% in the 1st quarter. Liontrust Investment Partners LLP now owns 60,650 shares of the financial services provider’s stock valued at $1,553,000 after purchasing an additional 11,658 shares in the last quarter. California State Teachers Retirement System grew its holdings in shares of Trupanion by 54.0% during the 1st quarter. California State Teachers Retirement System now owns 48,288 shares of the financial services provider’s stock worth $1,237,000 after purchasing an additional 16,930 shares during the period. Finally, Quantinno Capital Management LP grew its holdings in shares of Trupanion by 165.5% during the 1st quarter. Quantinno Capital Management LP now owns 24,712 shares of the financial services provider’s stock worth $633,000 after purchasing an additional 15,404 shares during the period.
Trupanion Stock Performance
The stock’s 50-day moving average is $24.50 and its 200-day moving average is $26.20. The stock has a market cap of $1.21 billion, a price-to-earnings ratio of 46.82 and a beta of 1.39. The company has a current ratio of 1.73, a quick ratio of 1.73 and a debt-to-equity ratio of 0.25.
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
See Also
- Five stocks we like better than Trupanion
- Boeing’s Comeback Is Building Momentum—Is It Real?
- Blueprint for a Banking Fortress: Circle Redraws the Map
- Bed Bath & Beyond Renovates: The Neighborhood Blueprint
- These Outperforming Giants Are Boosting Dividends in 2026, With Yields of Up to 6.6%
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
